Skip to main content
. 2017 Nov 27;8(69):113531–113542. doi: 10.18632/oncotarget.22697

Figure 1. Flow chart of patients evaluable for toxicity * received at least one cycle of allocated treatment; ddAC = dose-dense doxorubicin, cyclophosphamide; TAC = docetaxel, doxorubicin, cyclophosphamide.

Figure 1